Hyperthermia applications around the world and in our country are used in two ways: localized (regional) and whole-body. In localized hyperthermia, the targeted tissue area is accessed and heat energy is transferred through frequency-based application. This aims to increase the temperature of the targeted tissue. Although this method is precise and focused, it has not become widely used due to its cost and complexity of application. In addition, it may be difficult to apply in cases where the tumor is not easily accessible.

In whole-body hyperthermia applications, a solution containing particles responsive to heat during chemotherapy or radiotherapy is administered intravenously. The body is then heated to support the therapeutic processes intended for the targeted areas.

Both applications require clinical conditions. This means the patient must visit the hospital frequently throughout the treatment process. For elderly patients or those with advanced-stage conditions, daily transportation can be difficult and costly. Additionally, considering the risk of infection in cancer treatment, hospital visits may further increase vulnerability in patients with weakened immune systems.

To help reduce these challenges, we offer a “new-generation supportive therapy” approach. ETNA TECHNOLOGY provides not only clinical-type devices but also mobile therapy devices, allowing patients to receive supportive treatment in their own comfortable and controlled environments.

Instead of microwaves that generate heat, ETNA technology uses RF frequencies designed to interact with targeted cells for supportive therapeutic purposes. The aim is to influence the targeted cells without affecting surrounding healthy tissues. The method does not require selection of a specific body region; it supports resonance effects where targeted cellular activity is present.

Thanks to its portability and cost-efficiency, ETNA technology offers patients the convenience of receiving supportive therapy without the need for frequent hospital visits.